Metalloproteinases MMP-9, MMP-2 and their tissue inhibitors TIMP-1, TIMP-2 in peripheral transbronchial lung biopsies of patients with sarcoidosis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Polskie Archiwum Medycyny Wewnetrznej

• Publication date

  2009-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.20452/PAMW.789PMID 19847138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced pulmonary function is associated with enhanced inflammation and tissue inhibitor of metalloproteinase 1 concentration in the bronchoalveolar lavage fluid of patients with lung parenchymal sarcoidosis

  2009cited by this paper
• Reduced pulmonary function is associated with enhanced inflammation and tissue inhibitor of metalloproteinase 1 concentration in the bronchoalveolar lavage fluid of patients with lung parenchymal sarcoidosis.

  2008cited by this paper
• Reduced pulmonary function in wind instrument players.

  2006cited by this paper
• Carbon monoxide reduces the expression and activity of matrix metalloproteinases 1 and 2 in alveolar epithelial cells.

  2005cited by this paper
• Disorders of lung matrix remodeling.

  2004cited by this paper
• Extracellular matrix remodelling: the role of matrix metalloproteinases

  2003cited by this paper
• [Serum interleukin 6 (il-6A) concentration correlates with matrix metalloproteinases and their tissue inhibitors in rheumatoid arthritis].

  2003cited by this paper
• Clinical Investigations: AsthmaMatrix Metalloproteinase-9 Expression in Asthma: Effect of Asthma Severity, Allergen Challenge, and Inhaled Corticosteroids

  2002cited by this paper
• The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.

  2002cited by this paper
• Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.

  2002cited by this paper
• Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF

  2002cited by this paper
• Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity

  2002cited by this paper
• Induced sputum‐retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases

  2002cited by this paper
• British Thoracic Society guidelines on diagnostic flexible bronchoscopy.

  2001cited by this paper
• A novel role of metalloproteinase in cancer-mediated immunosuppression.

  2001cited by this paper
• Gelatinase B: a tuner and amplifier of immune functions.

  2001cited by this paper
• Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma.

  1999cited by this paper
• Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment.

  1999cited by this paper
• Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.

  1998cited by this paper
• Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.

  1998cited by this paper
• Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease.

  1997cited by this paper
• The role of antisecretory drugs in the treatment of Helicobacter pylori infection

  1997cited by this paper
• Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.

  1996cited by this paper
• Outcome of the treatment for sarcoidosis.

  1994cited by this paper
• Interstitial collagenase (MMP-1), gelatinase (MMP-2) and stromelysin (MMP-3) released by human fibroblasts cultured on acellular sarcoid granulomas (sarcoid matrix complex, SMC).

  1989cited by this paper
• Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity.

  1989cited by this paper
• Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis.

  1988cited by this paper
• Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes.

  1986cited by this paper
• Course and prognosis of sarcoidosis: London.

  1961cited by this paper

• Papular interstitial elastolytic giant cell granuloma concomitant with lichen amyloidosus in a type II diabetes patient

  2023cites this paper
• Models Contribution to the Understanding of Sarcoidosis Pathogenesis: “Are There Good Models of Sarcoidosis?”

  2020cites this paper
• Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy‐related inflammation

  2020cites this paper
• Andrographolide Enhances TRAIL-Induced Apoptosis via p53-Mediated Death Receptors Up-Regulation and Suppression of the NF-кB Pathway in Bladder Cancer Cells

  2019cites this paper
• Granulomatous lung inflammation is nanoparticle type-dependent

  2018cites this paper
• Andrographolide Inhibits Proliferation and Metastasis of SGC7901 Gastric Cancer Cells

  2017cites this paper
• Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients

  2017cites this paper
• Is Analysis of Exhaled Breath Condensate an Equivalent to Bronchoalveolar Lavage Fluid in Sarcoidos is Patients

  2012cites this paper
• The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis

  2011cites this paper
• Unbalanced MMP/TIMP-1 expression during the development of experimental pulmonary fibrosis with acute paraquat poisoning.

  2011cites this paper
• Investigation of gene expression of MMP-2 and TIMP-2 mRNA in rat lung in inhaled nickel oxide and titanium dioxide nanoparticles.

  2011cites this paper
• Modulation of immunopathogenic matrix metalloproteinases in pulmonary tuberculosis by T helper-17 cytokines & the PI 3-kinase pathway

  2011cites this paper
• A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?

  2011cites this paper